Following billionaire investor Warren Buffett into stocks he owns has often been a profitable strategy over the past few decades. But reversing the order��buying a stock before Buffett buys it��can potentially be even more rewarding.
Quiz: How Well Do You Really Know Warren Buffett?
With that in mind, we went prospecting for companies that Berkshire Hathaway (BRK-B, $137), Buffett��s holding company, has been buying recently, and four stocks that Buffett doesn��t hold but we think he ought to buy. We looked for the things he favors: com颅panies that are leaders in their industries, that have a strong commitment to sharing profit with investors, and whose stocks sell for relatively low prices compared with earnings and underlying asset value.
A few caveats: First, even Buffett makes mistakes. Second, many of Berkshire��s picks are now made by Buffett��s two investing deputies, Todd Combs and Ted Weschler, not Buffett himself. And third, anyone guessing which stocks might be attractive to Berkshire is doing just that��guessing.
Top Warren Buffett Stocks To Buy Right Now: Occidental Petroleum Corporation(OXY)
Advisors' Opinion:- [By Chris Lange]
Occidental Petroleum Corp.��s (NYSE: OXY) short interest increased to 11.05 million shares from the previous reading of 10.74 million. Shares recently traded at $83.20, in a 52-week range of $57.84 to $84.28.
- [By Chris Lange]
Occidental Petroleum Corp.��s (NYSE: OXY) short interest decreased to 8.98 million shares from the previous reading of 12.50 million. Shares recently traded at $85.66 in a 52-week range of $57.84 to $87.67.
- [By Joseph Griffin]
Oxycoin (CURRENCY:OXY) traded 3.1% higher against the dollar during the one day period ending at 19:00 PM E.T. on May 20th. One Oxycoin coin can currently be bought for approximately $0.11 or 0.00001305 BTC on exchanges including Livecoin and Bit-Z. Oxycoin has a total market cap of $12.09 million and approximately $23,963.00 worth of Oxycoin was traded on exchanges in the last day. During the last week, Oxycoin has traded 25.4% higher against the dollar.
- [By Max Byerly]
Get a free copy of the Zacks research report on Occidental Petroleum (OXY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Summit Trail Advisors LLC boosted its stake in Occidental Petroleum Co. (NYSE:OXY) by 5,726.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 584,759 shares of the oil and gas producer’s stock after buying an additional 574,723 shares during the quarter. Summit Trail Advisors LLC owned approximately 0.08% of Occidental Petroleum worth $585,000 at the end of the most recent reporting period.
- [By Stephan Byrd]
Occidental Petroleum (NYSE:OXY) was upgraded by investment analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research note issued on Monday, MarketBeat reports. The firm presently has a $98.00 target price on the oil and gas producer’s stock, up from their previous target price of $87.00. Jefferies Financial Group’s price target would indicate a potential upside of 15.39% from the company’s current price.
Top Warren Buffett Stocks To Buy Right Now: Rite Aid Corporation(RAD)
Advisors' Opinion:- [By Peter Graham]
Small�cap retail drugstore stock Rite Aid Corporation (NYSE: RAD) reported Q3 2018 earnings after the market closed Wednesday as the Company struggles with falling profits�in its pharmacy business as increases in branded drug prices have slowed while reimbursement pressure for generics has increased.
- [By Money Morning News Team]
�Rite Aid Corp. (NYSE: RAD) is a national drugstore chain known for providing both over-the-counter medicine and prescription pharmaceuticals.
Shares of the company have dropped over 60% in the last year due to bearish sentiment about the company's odds of holding on to its market share in the face of increasing competition from CVS Health Corp. (NYSE: CVS) and Wal-Mart Stores Inc. (NYSE: WMT).
- [By Max Byerly]
Glen Harbor Capital Management LLC purchased a new position in shares of Rite Aid Co. (NYSE:RAD) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 220,096 shares of the company’s stock, valued at approximately $370,000.
- [By Max Byerly]
Diplomat Pharmacy (NYSE: DPLO) and Rite Aid (NYSE:RAD) are both small-cap retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.
- [By Chris Lange]
Rite Aid Corp. (NYSE: RAD) fiscal third-quarter report is scheduled for late on Wednesday. Consensus estimates are calling for a net loss of $0.02 per share and $7.45 billion in revenue. The shares closed trading at $1.97 apiece on Friday. The consensus price target is $2.11, and the 52-week trading range is $1.38 to $8.77.
Top Warren Buffett Stocks To Buy Right Now: Fitbit, Inc.(FIT)
Advisors' Opinion:- [By Chris Neiger]
Apple (NASDAQ: AAPL) became the world's top maker of wearable tech just a few quarters ago, when it outpaced Fitbit (NYSE: FIT) for the first time. Apple Watch sales are still a small portion of its total revenues (the company doesn't break out Watch sales in its reports), but the growth rate of the consumer IoT device market indicates that there's still plenty of room for Apple to expand its wearable business.
- [By Timothy Green]
Shares of Fitbit (NYSE:FIT) jumped on Monday following the launch of its Ace children's wearable and a bullish report from Citron Research. The stock was up about 14.7% at market close.
- [By Harsh Chauhan]
Just three years ago, Fitbit (NYSE:FIT) was a dominant player in the wearables space thanks to the popularity of fitness trackers. Investors scrambled to get a piece of Fitbit as it looked all set to conquer the wearables market with a variety of fitness bands that were constantly updated�to stay ahead of the competition, giving the company an 80% share�of fitness trackers in the U.S.
- [By Motley Fool Staff]
In this segment from the Market Foolery podcast, host Chris Hill and David Kretzmann of Motley Fool Rule Breakers and Supernova weigh in on the latest numbers and guidance from Fitbit�(NYSE:FIT): The wearables leader beat expectations -- but still lost money -- in the first quarter. And with revenue and device sales down by double-digit percentages, there are real questions about how long its fitness bands can hold consumers' interest.
- [By Brian Withers]
Just when Fitbit (NYSE:FIT) investors were hoping for a glimmer of good news in the company's fourth quarter earnings report, it seems this wearable device maker's turnaround has stalled.
Top Warren Buffett Stocks To Buy Right Now: Civeo Corporation(CVEO)
Advisors' Opinion:- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results. Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1. Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report. FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2. Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results. National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results. United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results. Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million. athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results. Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results. Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10. Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings. AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results. CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results. Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results. LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO
Top Warren Buffett Stocks To Buy Right Now: H&E Equipment Services Inc.(HEES)
Advisors' Opinion:- [By Joseph Griffin]
SG Americas Securities LLC trimmed its holdings in shares of H&E Equipment Services, Inc. (NASDAQ:HEES) by 42.9% in the 1st quarter, Holdings Channel reports. The firm owned 4,026 shares of the industrial products company’s stock after selling 3,030 shares during the quarter. SG Americas Securities LLC’s holdings in H&E Equipment Services were worth $155,000 at the end of the most recent quarter.
- [By Peter Graham]
A long term performance chart shows shares of United Rentals�giving a similar performance but also�pulling away from�small cap peer H&E Equipment Services, Inc (NASDAQ: HEES):
- [By Shane Hupp]
H&E Equipment Services (NASDAQ: HEES) and WillScot (NASDAQ:WSC) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, institutional ownership and dividends.
Press coverage about Vistagen Therapeutics (NASDAQ:VTGN) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Vistagen Therapeutics earned a news sentiment score of 0.08 on Accern’s scale. Accern also gave news articles about the company an impact score of 44.1510836371046 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.